Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.15
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
See the full interactive analysis & chart →Informational only — not investment advice.